04-17-2007: Millipore Corporation announced that it is the first company to successfully integrate Radio Frequency Identification (RFID) technology with filtration products used to manufacture biopharmaceutical drugs. The new RFID capability will be branded as SMART Technology and will be introduced at the upcoming INTERPHEX(R) 2007 Conference.
According to the company, by using RFID technology in filtration products, Millipore's customers can increase their speed by quickly and reliably retrieving critical information, such as when and how the product was manufactured. Additionally, when the filters are coupled with sensors, RFID can deliver real-time information about product performance and identify which fluids are present during the manufacturing process. This information shall help customers to ensure regulatory compliance and make recording and conveying manufacturing data faster and more reliable.
Unlike previous labeling methods such as barcodes, RFID enables customers to automatically document product and process information, eliminates the risk of losing critical information, and provides the ability to rewrite their own information into embedded RFID tags.
Millipore has recently entered into an exclusive license with Tack Smart Filter Technology BV to embed the RFID technology in its filters and filtration apparatuses for biopharmaceutical applications. Additionally, Millipore has formed relationships with Tagsys RFID for tags and reader components; The Tech Group for injection molding and fabrication; and Northern Apex-RFID for RFID integration services and instrument development.
Watchlist
This is where you can add this news to your personal favourites
Merck KGaA announced the successful completion of its acquisition of Millipore Corporation, a leading Life Science company based in Billerica, Massachusetts, USA, for an aggregate purchase price including debt and cash of approximately EUR 5.2 billion (US$ 7.0 billion). Merck agreed to acqu ... more
Merck KGaA and Millipore Corporation announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore, for US$ 107 per share in cash, or a total transaction value, including net debt, of approximately € 5.3 ... more
Millipore Corporation announced the appointment of John Sweeney as Vice President of Millipore’s Life Science SBU. Most recently, Sweeney served as Vice President of Strategy and Marketing services for Millipore’s Bioscience Division.
Sweeney joined Millipore in 2003 as Director of Strateg ... more
To keep pace with the daily needs of your lab, you know it's crucial to have consistent pure water quality as well as the volumes of water you require more
Millipore is a life science leader providing cutting edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the worlds challenging human health issues. From research to development ... more
Millipore is a multinational company with offices and subsidiaries in 47 countries and distributors and dealers in other countries. There are manufacturing sites and R&D sites around the world. With its global infrastructure, Millipore services multinational pharmaceutical and biotechnology ... more